BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11917314)

  • 1. Estimating true burden of disease detected by screening tests of varying validity.
    Mishra RN; Mishra CP; Reddy DC; Gupta VM
    Indian J Public Health; 2001; 45(1):14-9. PubMed ID: 11917314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of a modified Parkinson's disease screening questionnaire in India: effects of literacy of participants and medical training of screeners and implications for screening efforts in developing countries.
    Sarangmath N; Rattihalli R; Ragothaman M; Gopalkrishna G; Doddaballapur S; Louis ED; Muthane UB
    Mov Disord; 2005 Dec; 20(12):1550-6. PubMed ID: 16078206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A general approach to sample size determination for prevalence surveys that use dual test protocols.
    Cheng D; Stamey JD; Branscum AJ
    Biom J; 2007 Aug; 49(5):694-706. PubMed ID: 17722203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capture-recapture and multiple-record systems estimation II: Applications in human diseases. International Working Group for Disease Monitoring and Forecasting.
    Am J Epidemiol; 1995 Nov; 142(10):1059-68. PubMed ID: 7485051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undetected burden of tuberculosis in a low-prevalence area.
    Baussano I; Bugiani M; Gregori D; van Hest R; Borraccino A; Raso R; Merletti F
    Int J Tuberc Lung Dis; 2006 Apr; 10(4):415-21. PubMed ID: 16602406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Should we screen for hemochromatosis? Critical analysis of the literature].
    Charvet-Protat S; Yaouanq J; Fleurette F
    Rev Epidemiol Sante Publique; 1997 Sep; 45(4):315-27. PubMed ID: 9380912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian sample size determination for prevalence and diagnostic test studies in the absence of a gold standard test.
    Dendukuri N; Rahme E; Bélisle P; Joseph L
    Biometrics; 2004 Jun; 60(2):388-97. PubMed ID: 15180664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the diagnosis of bipolar disorder: predictive value of screening tests.
    Phelps JR; Ghaemi SN
    J Affect Disord; 2006 Jun; 92(2-3):141-8. PubMed ID: 16529822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring congenital rubella embryopathy.
    Rittler M; López-Camelo J; Castilla EE
    Birth Defects Res A Clin Mol Teratol; 2004 Dec; 70(12):939-43. PubMed ID: 15558544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sensitivity, specificity and predictive values of methods of evaluation in psychiatry].
    Fombonne E; Fuhrer R
    Encephale; 1991; 17(2):73-7. PubMed ID: 2049997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel design for estimating relative accuracy of screening tests when complete disease verification is not feasible.
    Alonzo TA; Kittelson JM
    Biometrics; 2006 Jun; 62(2):605-12. PubMed ID: 16918926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal and nonfatal cardiovascular disease and the use of therapies for secondary prevention in a rural region of India.
    Joshi R; Chow CK; Raju PK; Raju R; Reddy KS; Macmahon S; Lopez AD; Neal B
    Circulation; 2009 Apr; 119(14):1950-5. PubMed ID: 19332466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating regional cancer burden in countries with partial registration coverage: an application to all malignant neoplasms in Italy over the period 1970-2010.
    Grande E; Inghelmann R; Francisci S; Verdecchia A; Micheli A; Capocaccia R; De Angelis R
    Eur J Cancer; 2006 Dec; 42(18):3236-45. PubMed ID: 17055719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region.
    Pirard M; Iihoshi N; Boelaert M; Basanta P; López F; Van der Stuyft P
    Transfusion; 2005 Apr; 45(4):554-61. PubMed ID: 15819677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based screening versus case detection.
    Thomas R; Parikh R; Paul P; Muliyil J
    Indian J Ophthalmol; 2002 Sep; 50(3):233-7. PubMed ID: 12355704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global estimation of foodborne diseases.
    Motarjemi Y; Käferstein FK
    World Health Stat Q; 1997; 50(1-2):5-11. PubMed ID: 9282382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of neonatal tetanus surveillance system in India.
    Singh J; Datta KK; Foster SO
    Indian Pediatr; 1997 May; 34(5):398-401. PubMed ID: 9332113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating sample size for a randomized clinical trial of lung cancer screening.
    Obuchowski NA
    Contemp Clin Trials; 2008 Jul; 29(4):466-77. PubMed ID: 18088564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.